Glycosmedia - an international diabetes news service from the UK
News
  Therapeutic inertia: underdiagnosed and undertreated hypertension in children participating in the T1D Exchange Clinic Registry
  HTN is likely under diagnosed and undertreated even in pediatric diabetes clinics. The relatively low proportion of hypertensive children receiving ACE-I therapy and reaching BP goals probably identifies an important area for improving care in children with type 1 diabetes (Pediatric Diabetes)
   
  Abnormal levels of age-elastin derived peptides in sera of diabetic patients with arterial hypertension
  The measurement of non-invasive markers of elastin glycation may be useful in monitoring development of vascular wall alterations and therapeutic interventions (Central European Journal of Immunology)
   
  Targets and Candidate Agents for Type 2 Diabetes Treatment with Computational Bioinformatics Approach
  In the present study, a systematic understanding for the mechanism underlying T2D development was provided with biological informatics methods. The significant nodes and bioactive small molecules may be drug targets and candidate agents for T2D treatment (Journal of Diabetes Research)
   
  Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study
  This finding suggests that more attention should be given to the management of cardiovascular risk in type 2 diabetic patients with high triglycerides levels (Cardiovascular Diabetology)
   
  Log (TG)/HDL-C ratio as a predictor of decreased islet beta cell function in patients with type 2 diabetes: 6-year cohort study
  In Chinese T2D patients, high baseline log (TG)/HDL-C ratio predicts fast progression of islet beta cell dysfunction. It may be a simple index to predict progression speed of islet beta cell dysfunction (Journal of Diabetes)
   
  Metformin powder formulation compared to metformin tablets on glycemic control and on treatment satisfaction in subjects with type 2 diabetes mellitus
  Metformin powder formulation seems to be more appropriate for the treatment of diabetic patients. The improvement of glycemic control suggests a better adherence to the powder formulation (Journal of Clinical Pharmacology)
   
  Evaluation of the effectiveness of liraglutide and sitagliptin in type 2 diabetes: a retrospective study in UK primary care
  Clinical trials show superior glycaemic control and weight reduction with liraglutide compared with sitagliptin. This finding is reflected in routine clinical practice in the UK (International Journal of Clinical Practice)
   
  Is insulin the most effective injectable antihyperglycaemic therapy?
  HbA1c reduction with the GLP-1RAs appears at least equivalent to that with basal insulin, irrespective of baseline HbA1c. This suggests that liraglutide and exenatide OW may be appropriate alternatives to basal insulin in type 2 diabetes, including when baseline HbA1c is very high (Diabetes, Obesity and Metabolism)
   
  Does treatment with an insulin pump improve glycaemic control in children and adolescents with type 1 diabetes? A retrospective case–control study
  This study shows that treatment with CSII resulted in an improvement in HbA1c levels up to 1yr and decreased the number of severe hypoglycaemic events, but the frequency of ketoacidosis increased (Pediatric Diabetes)
   
  New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Oral Agents and Basal Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 2)
  Gla-300 was as effective as Gla-100 and associated with a lower risk of hypoglycemia during the night and at any time of the day (Diabetes Care)
   
  Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes
  Demonstrates Proof-of-Concept for ORMD-0801 Oral Insulin to Reduce Exogenous Insulin Requirements (Oramed Pharmaceuticals)
   
  A pharmacogenetic association between a variation in calpain 10 (CAPN10) gene and the response to metformin treatment in patients with type 2 diabetes
  The present study provides the first observation of an association between a variant in CAPN10 gene and the response to metformin therapy in patients with type 2 diabetes. This observation needs to be replicated in further studies in different populations (European Journal of Clinical Pharmacology)
   

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.

Diabetes Weekly News Update - it's FREE!

Subscribe to our free weekly e-mail Please click here if you would like to subscribe to our free weekly e-mail.

Gold Sponsors

Sponsors


Our sponsors have provided unrestricted educational grants for the running of this website. None of these companies have any input to, or editorial control over the content of this website.

Advertisers

The first glucose monitoring device to support insulin therapy management with estimated HbA1c

The first glucose monitoring device to support insulin therapy management with estimated HbA1c.

The Diabetes Times

An online newspaper for the diabetes community.

 

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Book and Product Reviews

Book ReviewsA selection of book and product reviews written by the contributing editors of Glycosmedia.

Read the Reviews >>

FREE Glycosmedia iPhone and iPad App

FREE iPhone AppThe Glycosmedia App for iPhone and iPad is now available to download FREE from the iTunes store via this link.

Recommend Glycosmedia
Recommend Glycosmedia
Sponsorship and Advertising

Why sponsor Glycosmedia? >> click here

If you are interested in sponsorship or advertising opportunities with Glycosmedia then please contact the editor-in-chief Jim Young to discuss the options: jim@glycosmedia.com

 

© Copyright Glycosmedia Partnership
 

Site by Wired up Wales